{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:21:09Z","timestamp":1788992469381,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.modpat.2023.100253","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T01:53:13Z","timestamp":1687744393000},"page":"100253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0815-3741","authenticated-orcid":false,"given":"Kana","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tonooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Takakuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-5800","authenticated-orcid":false,"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2023.100253_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"issue":"12","key":"10.1016\/j.modpat.2023.100253_bib2","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41375-018-0154-5","article-title":"Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response","volume":"32","author":"Sakamoto","year":"2018","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.modpat.2023.100253_bib3","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.modpat.2023.100253_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.2830470406","article-title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma","volume":"47","author":"Adachi","year":"1994","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000478-199902000-00001","article-title":"CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?","volume":"23","author":"Petrella","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2023.100253_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-131-7-199910050-00035","article-title":"CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma","volume":"131","author":"Lucio","year":"1999","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.modpat.2023.100253_bib7","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2023.100253_bib8","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","article-title":"Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities","volume":"109","author":"Dijkman","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.200324531","article-title":"Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts","volume":"34","author":"Chaperot","year":"2004","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPFMNYCVPDEND0","article-title":"Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases","volume":"135","author":"Benet","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100253_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1309\/AJCP9IS9KFSVWKGH","article-title":"Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm","volume":"137","author":"Cronin","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100253_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1309\/0QPPAVTUPCV9UCLV","article-title":"TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis","volume":"122","author":"Petrella","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100253_bib14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.3800679","article-title":"Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms","volume":"19","author":"Jaye","year":"2006","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100253_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ccell.2016.10.002","article-title":"A\u00a0druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm","volume":"30","author":"Ceribelli","year":"2016","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.modpat.2023.100253_bib16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100253_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100253_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.modpat.2023.100253_bib19","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.modpat.2023.100253_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12185-016-1934-1","article-title":"ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern","volume":"103","author":"Sakamoto","year":"2016","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.modpat.2023.100253_bib21","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-08-3248","article-title":"KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer","volume":"15","author":"Takeuchi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjh.14146","article-title":"Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches","volume":"174","author":"Pagano","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100253_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","article-title":"TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow","volume":"88","author":"Alayed","year":"2013","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100253_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.modpat.2023.100253_bib26","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":"Novel markers of normal and neoplastic human plasmacytoid dendritic cells","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2023.100253_bib27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.leu.2404260","article-title":"The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells","volume":"20","author":"Pulford","year":"2006","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.modpat.2023.100253_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"10.1016\/j.modpat.2023.100253_bib29","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2011-03-337501","article-title":"Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion","volume":"118","author":"Lucioni","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2023.100253_bib30","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","article-title":"Elevated expression of IL-3R alpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis","volume":"100","author":"Testa","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.modpat.2023.100253_bib31","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/j.clml.2020.05.004","article-title":"A\u00a0real-world perspective of CD123 expression in acute leukemia as promising biomarker to predict treatment outcome in B-ALL and AML","volume":"20","author":"Das","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.modpat.2023.100253_bib32","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/bcj.2014.39","article-title":"Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia","volume":"4","author":"Ehninger","year":"2014","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cyto.b.21745","article-title":"CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping","volume":"96","author":"Bras","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"11","key":"10.1016\/j.modpat.2023.100253_bib34","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jegalian","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2023.100253_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2013-05-500413","article-title":"BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells","volume":"122","author":"Boiocchi","year":"2013","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:24:32Z","timestamp":1760232272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0893395223001588"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100253","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100253"}}